Literature DB >> 26929022

A Personalized Framework for Dynamic Modeling of Disease Trajectories in Chronic Lymphocytic Leukemia.

Symeon Savvopoulos, Ruth Misener, Nicki Panoskaltsis, Efstratios N Pistikopoulos, Athanasios Mantalaris.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most common peripheral blood and bone marrow cancer in the developed world. This manuscript proposes mathematical model equations representing the disease dynamics of B-cell CLL. We interconnect delay differential cell cycle models in each of the tumor-involved disease centers using physiologically relevant cell migration. We further introduce five hypothetical case studies representing CLL heterogeneity commonly seen in clinical practice and demonstrate how the proposed CLL model framework may capture disease pathophysiology across patient types. We conclude by exploring the capacity of the proposed temporally- and spatially distributed model to capture the heterogeneity of CLL disease progression. By using global sensitivity analysis, the critical parameters influencing disease trajectory over space and time are: 1) the initial number of CLL cells in peripheral blood, the number of involved lymph nodes, the presence and degree of splenomegaly; 2) the migratory fraction of nonproliferating as well as proliferating CLL cells from bone marrow into blood and of proliferating CLL cells from blood into lymph nodes; and 3) the parameters inducing nonproliferative cells to proliferate. The proposed model offers a practical platform that may be explored in future personalized patient protocols once validated.

Entities:  

Mesh:

Year:  2016        PMID: 26929022     DOI: 10.1109/TBME.2016.2533658

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  4 in total

1.  Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression.

Authors:  Qikai Zhang; Zongsi Zhu; Jiaqiang Guan; Yingying Hu; Wenjin Zhou; Wanchun Ye; Bijing Lin; Shanshan Weng; Yuemiao Chen; Cuiping Zheng
Journal:  Mol Biotechnol       Date:  2022-06-15       Impact factor: 2.860

2.  Improving personalized tumor growth predictions using a Bayesian combination of mechanistic modeling and machine learning.

Authors:  Pietro Mascheroni; Symeon Savvopoulos; Juan Carlos López Alfonso; Michael Meyer-Hermann; Haralampos Hatzikirou
Journal:  Commun Med (Lond)       Date:  2021-07-29

Review 3.  Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System.

Authors:  Haneen Banjar; David Adelson; Fred Brown; Naeem Chaudhri
Journal:  Biomed Res Int       Date:  2017-07-25       Impact factor: 3.411

4.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.